Zheng D et al. |
The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. |
2012 |
Bone |
pmid:22551876
|
Svensson M et al. |
Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. |
2012 |
Nephrol. Dial. Transplant. |
pmid:22172725
|
Terpos E et al. |
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. |
2011 Nov-Dec |
Clin. Exp. Rheumatol. |
pmid:22032557
|
Arikan F et al. |
C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. |
2011 Mar-Apr |
Int J Oral Maxillofac Implants |
pmid:21483881
|
Crespi R et al. |
Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. |
2011 Jul-Aug |
Int J Oral Maxillofac Implants |
pmid:21841997
|
Franke S et al. |
Advanced glycation end products affect growth and function of osteoblasts. |
2011 Jul-Aug |
Clin. Exp. Rheumatol. |
pmid:21906430
|
Rezg R et al. |
Inhibitors of vascular calcification as potential therapeutic targets. |
2011 Jul-Aug |
J. Nephrol. |
pmid:21688249
|
Reyes-GarcÃa R et al. |
[Cardiovascular disease and bone metabolism]. |
2011 Aug-Sep |
Endocrinol Nutr |
pmid:21775224
|
Tsioufis C et al. |
Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction. |
2011 |
Expert Opin. Ther. Targets |
pmid:22136618
|
Zhou J et al. |
Expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in root resorption induced by heavy force in rats. |
2011 |
J Orofac Orthop |
pmid:22138776
|
Grzibovskis M et al. |
Specific signaling molecule expressions in the interradicular septum in different age groups. |
2011 |
Stomatologija |
pmid:22071415
|
Chang YC and Zhao JH |
Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. |
2011 |
Aust Dent J |
pmid:22126345
|
Weinstein RS et al. |
Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. |
2011 |
Endocrinology |
pmid:21771887
|
Lee JH et al. |
Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis. |
2011 |
BMB Rep |
pmid:21777519
|
Baldi D et al. |
Dental implants osteogenic properties evaluated by cDNA microarrays. |
2011 |
Implant Dent |
pmid:21778890
|
Kwan JS et al. |
Heritability of serum osteoprotegerin. |
2011 |
Ann. Hum. Genet. |
pmid:21762114
|
Ibrahim T et al. |
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. |
2011 |
Clin. Breast Cancer |
pmid:21764390
|
Yamamoto K et al. |
Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. |
2011 |
Oral Dis |
pmid:21771211
|
Chen WJ et al. |
Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. |
2011 |
Cardiovasc Diabetol |
pmid:21771299
|
Pepene CE et al. |
Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism. |
2011 |
Clin Invest Med |
pmid:21810381
|
Sheng L et al. |
[Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. |
2011 |
Zhongguo Zhong Xi Yi Jie He Za Zhi |
pmid:21812275
|
Nakashima A et al. |
Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients. |
2011 |
Osteoporos Int |
pmid:20812007
|
Chen WF et al. |
Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. |
2011 |
Br. J. Nutr. |
pmid:20815976
|
Zinonos I et al. |
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. |
2011 |
J. Bone Miner. Res. |
pmid:20818644
|
Loncar G et al. |
Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. |
2011 |
J. Endocrinol. Invest. |
pmid:20820131
|
Gradosova I et al. |
The role of atorvastatin in bone metabolism in male albino Wistar rats. |
2011 |
Pharmazie |
pmid:21901984
|
Straface G et al. |
Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. |
2011 |
Stroke |
pmid:21903966
|
Tripathi A et al. |
Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns. |
2011 |
J Prosthodont |
pmid:21883630
|
Mohamed GB and Abdel-Latif EA |
Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. |
2011 |
Saudi J Kidney Dis Transpl |
pmid:21912025
|
Lommi JI et al. |
High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. |
2011 |
Atherosclerosis |
pmid:21917259
|
Embree M et al. |
Role of subchondral bone during early-stage experimental TMJ osteoarthritis. |
2011 |
J. Dent. Res. |
pmid:21917603
|
D'Amelio P et al. |
Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. |
2011 |
Osteoporos Int |
pmid:21116815
|
Giner M et al. |
Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. |
2011 |
Eur. J. Pharmacol. |
pmid:21050847
|
To M et al. |
Osteoprotegerin in sputum is a potential biomarker in COPD. |
2011 |
Chest |
pmid:21127170
|
Witasp A et al. |
Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. |
2011 |
Eur. J. Clin. Invest. |
pmid:21128937
|
Khoshniat S et al. |
Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. |
2011 |
Bone |
pmid:21147284
|
Gulseren A et al. |
Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. |
2011 |
Panminerva Med |
pmid:21659972
|
Corallini F et al. |
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. |
2011 |
J. Cell. Physiol. |
pmid:21660951
|
Roshandel D et al. |
Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men. |
2011 |
Calcif. Tissue Int. |
pmid:21964949
|
Costa-Rodrigues J and Fernandes MH |
Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts. |
2011 |
Cell Prolif. |
pmid:21535267
|
Davenport C et al. |
Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk. |
2011 |
J. Hypertens. |
pmid:21970938
|
Lee YS and Choi EM |
Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. |
2011 |
Cell. Immunol. |
pmid:21683946
|
Hossein-nezhad A et al. |
The influence of folic acid supplementation on maternal and fetal bone turnover. |
2011 |
J. Bone Miner. Metab. |
pmid:20602129
|
Miyamoto K et al. |
Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. |
2011 |
J. Exp. Med. |
pmid:22006978
|
Schoppet M et al. |
Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21371424
|
Quemerais-Durieu MA et al. |
[Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. |
2011 |
Ann. Endocrinol. (Paris) |
pmid:22008272
|
Pobeha P et al. |
Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. |
2011 |
Bone |
pmid:21376149
|
Koo HM et al. |
Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. |
2011 |
Atherosclerosis |
pmid:22015178
|
Krause U et al. |
Assays of osteogenic differentiation by cultured human mesenchymal stem cells. |
2011 |
Methods Mol. Biol. |
pmid:21431522
|
Clemens TL and Karsenty G |
The osteoblast: an insulin target cell controlling glucose homeostasis. |
2011 |
J. Bone Miner. Res. |
pmid:21433069
|
Galliera E et al. |
Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? |
2011 |
Inflamm. Bowel Dis. |
pmid:21433226
|
Cao H et al. |
Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. |
2011 |
Circ. J. |
pmid:22001292
|
Hou L et al. |
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. |
2011 |
Acta Vet. Scand. |
pmid:21435269
|
Baloul SS et al. |
Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. |
2011 |
Am J Orthod Dentofacial Orthop |
pmid:21435543
|
Ferrari-Lacraz S and Ferrari S |
Do RANKL inhibitors (denosumab) affect inflammation and immunity? |
2011 |
Osteoporos Int |
pmid:20571772
|
Siomou E et al. |
Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. |
2011 |
Pediatr. Nephrol. |
pmid:21479768
|
Sexton WM et al. |
Salivary biomarkers of periodontal disease in response to treatment. |
2011 |
J. Clin. Periodontol. |
pmid:21480939
|
Mödder UI et al. |
Regulation of circulating sclerostin levels by sex steroids in women and in men. |
2011 |
J. Bone Miner. Res. |
pmid:20499362
|
Cordeiro MM et al. |
Primary teeth show less protecting factors against root resorption. |
2011 |
Int J Paediatr Dent |
pmid:21481035
|
Mainini G et al. |
Serum osteoprotegerin correlates with age and bone mass in postmenopausal, but not in fertile age women. |
2011 |
Clin Exp Obstet Gynecol |
pmid:22268274
|
Kaneuji T et al. |
Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21459078
|
Luvizuto ER et al. |
Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats. |
2011 |
Arch. Oral Biol. |
pmid:21536255
|
Riksen EA et al. |
Human osteoblastic cells discriminate between 20-kDa amelogenin isoforms. |
2011 |
Eur. J. Oral Sci. |
pmid:22243268
|
Al-Dujaili SA et al. |
Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. |
2011 |
J. Cell. Biochem. |
pmid:21538477
|
Stępień E et al. |
Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. |
2011 |
Clin. Biochem. |
pmid:21539822
|
Yang Z et al. |
[Effects of negative pressure on osteogenesis in human bone marrow-derived stroma cells cultured in vitro]. |
2011 |
Zhongguo Gu Shang |
pmid:22276514
|
Zheng Y et al. |
Vitamin D deficiency promotes prostate cancer growth in bone. |
2011 |
Prostate |
pmid:21541977
|
Park JS et al. |
Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. |
2011 |
Eur. J. Endocrinol. |
pmid:20961967
|
Karosi T et al. |
Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. |
2011 |
Eur Arch Otorhinolaryngol |
pmid:20963600
|
Halade GV et al. |
Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. |
2011 |
Exp. Gerontol. |
pmid:20923699
|
Mitsuhashi M et al. |
Effects of HSP70 on the compression force-induced TNF-α and RANKL expression in human periodontal ligament cells. |
2011 |
Inflamm. Res. |
pmid:20924639
|
Huang CH et al. |
Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. |
2011 |
Rheumatology (Oxford) |
pmid:20974615
|
WaluÅ›-Miarka M et al. |
Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients. |
2011 |
Int. J. Cardiol. |
pmid:21255853
|
Saito CT et al. |
Effect of low-level laser therapy on the healing process after tooth replantation: a histomorphometrical and immunohistochemical analysis. |
2011 |
Dent Traumatol |
pmid:21244626
|
Erkol A et al. |
Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. |
2011 |
Am. J. Cardiol. |
pmid:21247537
|
Bai P et al. |
Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. |
2011 |
Respir. Res. |
pmid:22176920
|
Sobue T et al. |
Murine TMJ loading causes increased proliferation and chondrocyte maturation. |
2011 |
J. Dent. Res. |
pmid:21248355
|
Ribeiro FV et al. |
Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. |
2011 |
J. Periodontol. |
pmid:21284550
|
Vik A et al. |
Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. |
2011 |
J. Thromb. Haemost. |
pmid:21284802
|
Piedra M et al. |
"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". |
2011 |
BMC Med. Genet. |
pmid:22185226
|
Hasegawa T et al. |
[Animal models for bone and joint disease. Bone disease of osteoprotegerin deficient mouse]. |
2011 |
Clin Calcium |
pmid:21289415
|
Qu Z et al. |
Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. |
2011 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:21232997
|
Rauch A et al. |
An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. |
2011 |
FASEB J. |
pmid:21233489
|
Caetano-Lopes J et al. |
Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. |
2011 |
PLoS ONE |
pmid:21347301
|
Assmann G et al. |
Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study. |
2011 |
J. Dermatol. |
pmid:21352301
|
Audo R et al. |
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis. |
2011 |
Arthritis Rheum. |
pmid:21305500
|
Alexander KA et al. |
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. |
2011 |
J. Bone Miner. Res. |
pmid:21305607
|
Jabbar S et al. |
Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. |
2011 |
J. Clin. Pathol. |
pmid:21307155
|
Maïmoun L et al. |
In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. |
2011 |
Osteoporos Int |
pmid:21359671
|
Polzer K et al. |
Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. |
2011 |
Arthritis Rheum. |
pmid:21360496
|
Oshita K et al. |
Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. |
2011 |
Arthritis Rheum. |
pmid:21360521
|
Wang SY et al. |
Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. |
2011 |
J. Rheumatol. |
pmid:21362762
|
Ignatius A et al. |
Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β. |
2011 |
J. Cell. Biochem. |
pmid:21598302
|
Preshaw PM and Taylor JJ |
How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? |
2011 |
J. Clin. Periodontol. |
pmid:21323705
|
Sun CX et al. |
[Patterns of osteoprotegerin or nuclear factor kappa B ligand gene expression in the treatment of bone defect with bone marrow stem cell transplantation and low-frequency vibration]. |
2011 |
Zhonghua Yi Xue Za Zhi |
pmid:21600122
|
Basu R et al. |
Effects of physiological variations in circulating insulin levels on bone turnover in humans. |
2011 |
J. Clin. Endocrinol. Metab. |
pmid:21325461
|
Liu ZF et al. |
[Effect of ultrasound on osteoprotegerin and receptor activator nuclear factor kappaB ligand expression during root resorption in rats]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:21602131
|
Blázquez-Medela AM et al. |
Osteoprotegerin and diabetes-associated pathologies. |
2011 |
Curr. Mol. Med. |
pmid:21568931
|
Peng S et al. |
Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. |
2011 |
J. Bone Miner. Res. |
pmid:21611968
|
Mai QG et al. |
Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. |
2011 |
J. Cell. Biochem. |
pmid:21618594
|